| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/09/2006 | CA2573894A1 Stabilized pancreas product |
| 02/08/2006 | EP1624073A1 Drug |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1624065A2 Agarase and gene thereof |
| 02/08/2006 | EP1624060A2 Control of gene expression |
| 02/08/2006 | EP1624057A2 Process for the obtention of a composition containing hyaluronidase |
| 02/08/2006 | EP1624056A1 Novel Geobacillus microorganism |
| 02/08/2006 | EP1624050A2 Multiply-substituted protease variants |
| 02/08/2006 | EP1623995A1 Inhibitors of L1 and ADAM10 for the treatment of carcinomas |
| 02/08/2006 | EP1623994A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/08/2006 | EP1623993A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623974A1 2"-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 02/08/2006 | EP1623232A2 Enrichment of enzymatic cleavage products |
| 02/08/2006 | EP1623031A1 A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar. |
| 02/08/2006 | EP1623030A2 Topoisomerase hybrids and methods of use |
| 02/08/2006 | EP1623029A1 Variant subtilisin enzymes (subtilases) |
| 02/08/2006 | EP1623028A1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors |
| 02/08/2006 | EP1623027A1 Ubp1 protease mutants, their coding sequences, application and methods of production |
| 02/08/2006 | EP1623026A1 Crystal of pde5, its crystal structure and its use in drug design |
| 02/08/2006 | EP1623025A1 Glucose dehydrogenase and production thereof |
| 02/08/2006 | EP1623024A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 02/08/2006 | EP1623008A2 Pufa polyketide synthase systems and uses thereof |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622643A2 Avian combination-vaccine against e. coli and salmonella |
| 02/08/2006 | EP1622638A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1442126B1 Method for selecting genetically transformed cells |
| 02/08/2006 | EP1414998A4 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1032680B1 A novel method for the integration of foreign dna into eukaryoticgenomes |
| 02/08/2006 | EP1032669B1 Recombinant allergen with reduced enzymatic activity |
| 02/08/2006 | EP0783527B1 Cathepsin o2 protease |
| 02/08/2006 | EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 02/08/2006 | CN1732272A Assay for rnase h activity |
| 02/08/2006 | CN1732259A Method of degrading hardly degradable protein |
| 02/08/2006 | CN1730657A Chlorothricin biological synthesis gene cluster and its uses |
| 02/08/2006 | CN1730653A Aspergillus niger lipase and its preparation method |
| 02/08/2006 | CN1730528A Bactericidal enzyme agglomerate, bactericidal enzyme polymer monofilament and its preparing process and uses |
| 02/08/2006 | CN1240833C Novel nitrile hydratase |
| 02/08/2006 | CN1240832C Alkaline bacillus amylase |
| 02/08/2006 | CN1240386C Matrix metal proteinase and tumor necrosis inhibitor |
| 02/07/2006 | US6995300 Isolation of SU1, a starch debranching enzyme, the product of the maize gene sugary1 |
| 02/07/2006 | US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C |
| 02/07/2006 | US6995254 Given sequences; vectors; host cells; use as a drug target to screen for novel antibiotics as FAB I is involved in bacterial fatty acid biosynthesis |
| 02/07/2006 | US6995250 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 02/07/2006 | US6995177 HCV NS3 protease inhibitors |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | US6995005 A cultured product, water soluble, molecular weight of 27,400 Daltons to 28,200 Daltons; polyclonal antibody, hybridoma cell produces monoclonal antibody; activating biodegradation of ester compound, polyester homo- or copolymers |
| 02/07/2006 | US6995004 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β 1,3-N-ACETYLGALACTOSAMINE-α-R / N-ACETYLGLUCOSAMINE-β 1,3,-N-ACETYLGALACTOSAMINE-α-R (GLCNAC TO GALNAC) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GNT |
| 02/07/2006 | US6995003 Altering the consensus C-terminal targeting sequence of desacetoxycephalosporin C synthetase, a modified enzymes expressed from recombinant DNA in host cell Penicillium chrysogenum; improve cephalosporins production |
| 02/07/2006 | US6995002 Nucleotide sequences which code for the mdhA gene |
| 02/07/2006 | US6994998 substituting a base-modified nucleotide that renders the polynucleotide more susceptible to cleavage at the sites of its incorporation for a natural nucleotide in a polynucleotide; 1-ribose-4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one for example |
| 02/07/2006 | US6994997 Gram positive bacteria deprived of HtrA protease activity and their uses |
| 02/07/2006 | US6994996 polypeptide able to regulate ATPase activity; use treating various disease such as malignant tumors, hemopathies, HIV infections, immune diseases and inflammations |
| 02/07/2006 | US6994986 Generation of preferential polypeptides; generate reaction mixtures, insert amino acid, recover polypeptides |
| 02/07/2006 | US6994978 Human osteoclast derived cathepsin |
| 02/07/2006 | US6994974 Drug screening for a substance that inhibits endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide from binding to amyloid-beta peptide; neurodegenerative disorders |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/07/2006 | US6994847 Stabilized interferon compositions |
| 02/07/2006 | CA2207264C Reversible nuclear genetic system for male sterility in transgenic plants |
| 02/07/2006 | CA1341494C Plants with modified stamen cells |
| 02/02/2006 | WO2006012326A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 02/02/2006 | WO2006012325A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 02/02/2006 | WO2006012309A1 Inducible inactivation of synaptic transmission |
| 02/02/2006 | WO2006012080A2 Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases |
| 02/02/2006 | WO2006011479A1 Processes for producing cellooligosaccharide |
| 02/02/2006 | WO2006010940A1 Method of assaying fad synthetase |
| 02/02/2006 | WO2006010920A1 Soluble polypeptide |
| 02/02/2006 | WO2006010887A1 Chimeric dna polymerase |
| 02/02/2006 | WO2006010646A1 Method for producing highly sensitive endonucleases, novel preparations of endonucleases and uses thereof |
| 02/02/2006 | WO2006010498A2 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 02/02/2006 | WO2006010496A1 Diagnostics and therapeutics for diseases associated with dipeptidase 1 (dpep1) |
| 02/02/2006 | WO2006010493A1 Diagnostics and therapeutics for diseases associated with ethanolamine kinase 1 (ek11) |
| 02/02/2006 | WO2005120222A3 Genetically modified non-human mammals and cells |
| 02/02/2006 | WO2005087934A3 Barley for production of flavor-stable beverage |
| 02/02/2006 | WO2005087920A3 Recombinant chondroitinase abc i and uses thereof |
| 02/02/2006 | WO2005035752A3 Materials and methods for synthesis of a flavor and aroma volatile in plants |
| 02/02/2006 | WO2005005626A8 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 02/02/2006 | WO2005004809A3 Multivalent carriers of bi-specific antibodies |
| 02/02/2006 | WO2004101755A3 Ref1 modified plants and plant seeds |
| 02/02/2006 | WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 02/02/2006 | WO2004037990A3 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
| 02/02/2006 | WO2004001011A3 Nematode phosphoethanolamine n-methyltransferase-like sequences |
| 02/02/2006 | US20060026721 Plant cellulose synthases |
| 02/02/2006 | US20060026720 Plant proteins |
| 02/02/2006 | US20060026715 Commercial production of polysaccharide degrading enzymes in plants and methods of using same |
| 02/02/2006 | US20060026713 Nucleotide sequences coding beta ketoacyl-acyl carrier protein synthase II for use in modifying fatty acid concentration in crop plants |
| 02/02/2006 | US20060026705 Plant amino acid biosynthetic enzymes |
| 02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/02/2006 | US20060025371 Methods of inhibiting COX-2 |
| 02/02/2006 | US20060025369 Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
| 02/02/2006 | US20060025356 28-epirapalogs |
| 02/02/2006 | US20060025350 4-hydroxy-2-hydroxymethyl-pyrrolidin-3-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024809 Ceramidase gene |
| 02/02/2006 | US20060024808 Covalent tethering of functional groups to proteins and substrates therefor |
| 02/02/2006 | US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors |
| 02/02/2006 | US20060024806 Mycolactone locus: an assembly line for producing novel polyketides, therapeutic and prophylactic uses |
| 02/02/2006 | US20060024805 Disintegrin homologs |